Global healthcare company Berkeley Health will showcase its growing portfolio of rapid at-home self-test kits at WHX Miami 2026, highlighting its continued international expansion and commitment to accessible healthcare solutions.
With more than 600 million self-tests distributed globally, Berkeley Health has established itself as a trusted provider of fast, accurate and reliable health monitoring products designed for use in the home. The company’s products are now available in over 30 countries through retail, pharmacy and eCommerce channels.
At the event, Berkeley Health will present a broad range of rapid self-test kits spanning multiple healthcare categories, including vitamin deficiency, hormone health, digestive health, inflammation, infectious diseases and respiratory conditions.
The portfolio on display will include self-tests for Vitamin D Deficiency, Prostate PSA, Iron FER (Iron Deficiency), Thyroid TSH, Allergy IgE, Kidney Albumin, Menopause FSH, Ovulation LH, Sperm Count and Vaginal pH. The company will also showcase tests for Urinary Tract Infection (UTI), Celiac disease, Bowel FOB (Bowel Health), H. Pylori, C-Reactive Protein, HIV, Chlamydia, Multi-Drug screening and Strep A.
Among the latest additions to the range is Berkeley Health’s 5-in-1 respiratory test, designed to detect SARS-CoV-2, Flu A+B, RSV and Adenovirus from a single test kit.
Jon Hughes from Berkeley Health said: “At Berkeley Health, we are committed to making healthcare more accessible through reliable, easy-to-use self-testing solutions that empower people to better understand and manage their health from home. WHX Miami 2026 provides an exciting opportunity to showcase our growing product portfolio and continue building partnerships that support the future of accessible healthcare worldwide.”
Berkeley Health says its products are developed to rigorous quality standards and are CE Marked, MHRA Registered, FDA Registered and ISO Certified. The company positions its self-testing solutions as simple, convenient and accessible, helping individuals gain health insights quickly from the comfort of home.
The company recently secured FDA Registration, further strengthening its regulatory credentials as it expands across international markets. Berkeley Health also supplies products to the National Health Service and works with major UK retailer Waitrose to make self-testing products more widely accessible to consumers.
In addition, several Berkeley Health menopause-related products have received GenM M-Tick accreditation, recognising products designed to support menopause awareness and accessibility.
As part of its ongoing global growth strategy, Berkeley Health has recently expanded into 11 additional international markets, including China, Pakistan, Qatar, Iraq, United States, Cyprus, Malta, Netherlands, Luxembourg, Estonia, Latvia and Lithuania, strengthening the company’s international distribution network and presence within the global healthcare market.
For more information visit https://www.berkeleyhealth.com/
